Audiology And Neurotology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1087580, encodeId=a6b5108e58090, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087579, encodeId=6419108e57910, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848087, encodeId=a1c184808ee3, content=审稿速度:4.0 经验分享：每年发文量有点少，可以中的概率有点低，老板非要让我投这个期刊试试，诶 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17a5413995, createdName=ms4097232105300978, createdTime=Thu Nov 08 11:42:02 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534123, encodeId=2a435341234d, content=201611004 Revision 0 The effect of ... Submitted: 08/11/2016 Current Status: Under Review 四个月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677940312, createdName=sanming1978, createdTime=Sun Mar 12 19:20:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532889, encodeId=192653288945, content=Manuscripts Currently Under Consideration (1 manuscript) 201611004 Revision 0 The effect ... Submitted: 08/11/2016 Current Status: Under Review 已经三个多月了，发信问也不回，该如何是好？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677940312, createdName=sanming1978, createdTime=Thu Feb 16 10:38:00 CST 2017, time=2017-02-16, status=1, ipAttribution=)]

2021-12-29 ms6000000264964247

引言和讨论如何写的不重复？

41 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1087580, encodeId=a6b5108e58090, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087579, encodeId=6419108e57910, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848087, encodeId=a1c184808ee3, content=审稿速度:4.0 经验分享：每年发文量有点少，可以中的概率有点低，老板非要让我投这个期刊试试，诶 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17a5413995, createdName=ms4097232105300978, createdTime=Thu Nov 08 11:42:02 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534123, encodeId=2a435341234d, content=201611004 Revision 0 The effect of ... Submitted: 08/11/2016 Current Status: Under Review 四个月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677940312, createdName=sanming1978, createdTime=Sun Mar 12 19:20:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532889, encodeId=192653288945, content=Manuscripts Currently Under Consideration (1 manuscript) 201611004 Revision 0 The effect ... Submitted: 08/11/2016 Current Status: Under Review 已经三个多月了，发信问也不回，该如何是好？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677940312, createdName=sanming1978, createdTime=Thu Feb 16 10:38:00 CST 2017, time=2017-02-16, status=1, ipAttribution=)]

2021-12-28 msSSSSSD

怎么撰写引言？区别于讨论？

34 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1087580, encodeId=a6b5108e58090, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087579, encodeId=6419108e57910, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848087, encodeId=a1c184808ee3, content=审稿速度:4.0 经验分享：每年发文量有点少，可以中的概率有点低，老板非要让我投这个期刊试试，诶 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17a5413995, createdName=ms4097232105300978, createdTime=Thu Nov 08 11:42:02 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534123, encodeId=2a435341234d, content=201611004 Revision 0 The effect of ... Submitted: 08/11/2016 Current Status: Under Review 四个月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677940312, createdName=sanming1978, createdTime=Sun Mar 12 19:20:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532889, encodeId=192653288945, content=Manuscripts Currently Under Consideration (1 manuscript) 201611004 Revision 0 The effect ... Submitted: 08/11/2016 Current Status: Under Review 已经三个多月了，发信问也不回，该如何是好？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677940312, createdName=sanming1978, createdTime=Thu Feb 16 10:38:00 CST 2017, time=2017-02-16, status=1, ipAttribution=)]

2018-11-08 ms4097232105300978

审稿速度:4.0
经验分享：每年发文量有点少，可以中的概率有点低，老板非要让我投这个期刊试试，诶

73 0

[GetPortalCommentsPageByObjectIdResponse(id=1087580, encodeId=a6b5108e58090, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087579, encodeId=6419108e57910, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848087, encodeId=a1c184808ee3, content=审稿速度:4.0 经验分享：每年发文量有点少，可以中的概率有点低，老板非要让我投这个期刊试试，诶 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17a5413995, createdName=ms4097232105300978, createdTime=Thu Nov 08 11:42:02 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534123, encodeId=2a435341234d, content=201611004 Revision 0 The effect of ... Submitted: 08/11/2016 Current Status: Under Review 四个月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677940312, createdName=sanming1978, createdTime=Sun Mar 12 19:20:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532889, encodeId=192653288945, content=Manuscripts Currently Under Consideration (1 manuscript) 201611004 Revision 0 The effect ... Submitted: 08/11/2016 Current Status: Under Review 已经三个多月了，发信问也不回，该如何是好？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677940312, createdName=sanming1978, createdTime=Thu Feb 16 10:38:00 CST 2017, time=2017-02-16, status=1, ipAttribution=)]

2017-03-12 sanming1978

201611004 Revision 0 The effect of ...
Submitted: 08/11/2016 Current Status: Under Review 四个月了

190 0

[GetPortalCommentsPageByObjectIdResponse(id=1087580, encodeId=a6b5108e58090, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087579, encodeId=6419108e57910, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848087, encodeId=a1c184808ee3, content=审稿速度:4.0 经验分享：每年发文量有点少，可以中的概率有点低，老板非要让我投这个期刊试试，诶 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17a5413995, createdName=ms4097232105300978, createdTime=Thu Nov 08 11:42:02 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534123, encodeId=2a435341234d, content=201611004 Revision 0 The effect of ... Submitted: 08/11/2016 Current Status: Under Review 四个月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677940312, createdName=sanming1978, createdTime=Sun Mar 12 19:20:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532889, encodeId=192653288945, content=Manuscripts Currently Under Consideration (1 manuscript) 201611004 Revision 0 The effect ... Submitted: 08/11/2016 Current Status: Under Review 已经三个多月了，发信问也不回，该如何是好？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677940312, createdName=sanming1978, createdTime=Thu Feb 16 10:38:00 CST 2017, time=2017-02-16, status=1, ipAttribution=)]

2017-02-16 sanming1978

Manuscripts Currently Under Consideration (1 manuscript)
201611004 Revision 0 The effect ...
Submitted: 08/11/2016 Current Status: Under Review
已经三个多月了，发信问也不回，该如何是好？？？？

144 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务